{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:14:37Z","timestamp":1792181677314,"version":"4.4.0"},"reference-count":57,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00687","type":"journal-article","created":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T03:45:42Z","timestamp":1498448742000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["A Bivalent Anthrax\u2013Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis"],"prefix":"10.3389","volume":"8","author":[{"given":"Pan","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marthandan","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Moayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Kirtley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Fitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jourdan A.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok K.","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venigalla B.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1086\/313794","article-title":"Preventing the use of biological weapons: improving response should prevention fail","volume":"30","author":"Inglesby","year":"2000","journal-title":"Clin Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0140-6736(00)02751-3","article-title":"Facing the biological weapons threat","volume":"356","author":"O\u2019Toole","year":"2000","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-micro-091014-104523","article-title":"Anthrax pathogenesis","volume":"69","author":"Moayeri","year":"2015","journal-title":"Annu Rev Microbiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3389\/fmicb.2015.01009","article-title":"Anthrax prophylaxis: recent advances and future directions","volume":"6","author":"Williamson","year":"2015","journal-title":"Front Microbiol"},{"key":"B7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21236\/ADA403352","volume-title":"The Anthrax Vaccine: Is it Safe? Does it Work?","author":"Joellenbeck","year":"2002"},{"key":"B8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1172\/JCI0216204","article-title":"Development of an improved vaccine for anthrax","volume":"110","author":"Leppla","year":"2002","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.vaccine.2015.11.025","article-title":"Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen-the first step toward a rationally designed anthrax vaccine","volume":"34","author":"McComb","year":"2016","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1016\/j.vaccine.2016.06.041","article-title":"Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing","volume":"34","author":"Stark","year":"2016","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"B12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/10408410500496896","article-title":"The anti-plague system and the Soviet biological warfare program","volume":"32","author":"Zilinskas","year":"2006","journal-title":"Crit Rev Microbiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2174\/1389201014666131226122243","article-title":"Rational considerations about development of live attenuated Yersinia pestis vaccines","volume":"14","author":"Sun","year":"2013","journal-title":"Curr Pharm Biotechnol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142728","article-title":"Anthrax toxin: receptor binding, internalization, pore formation, and translocation","volume":"76","author":"Young","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"B15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1586\/14760584.2013.814860","article-title":"Anthrax vaccines: present status and future prospects","volume":"12","author":"Kaur","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1128\/CVI.00174-12","article-title":"Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant","volume":"19","author":"Wagner","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/jps.23422","article-title":"Rapid deamidation of recombinant protective antigen when adsorbed on aluminum hydroxide gel correlates with reduced potency of vaccine","volume":"102","author":"D\u2019Souza","year":"2013","journal-title":"J Pharm Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00253-011-3380-6","article-title":"Progress on plague vaccine development","volume":"91","author":"Rosenzweig","year":"2011","journal-title":"Appl Microbiol Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1371\/journal.pmed.0050003","article-title":"Plague: past, present, and future","volume":"5","author":"Stenseth","year":"2008","journal-title":"PLoS Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.str.2004.01.010","article-title":"The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague","volume":"12","author":"Derewenda","year":"2004","journal-title":"Structure"},{"key":"B21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1107\/S1744309113008579","article-title":"Structure of the Yersinia pestis tip protein LcrV refined to 1.65 A resolution","volume":"69","author":"Chaudhury","year":"2013","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1000573","DOI":"10.1371\/journal.ppat.1000573","article-title":"CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells","volume":"5","author":"Bergman","year":"2009","journal-title":"PLoS Pathog"},{"key":"B23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.4269\/ajtmh.1998.58.793","article-title":"Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice","volume":"58","author":"Anderson","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1003495","DOI":"10.1371\/journal.ppat.1003495","article-title":"Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines","volume":"9","author":"Tao","year":"2013","journal-title":"PLoS Pathog"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/978-1-4939-3387-7_28","article-title":"Highly effective soluble and bacteriophage T4 nanoparticle plague vaccines against Yersinia pestis","volume":"1403","author":"Tao","year":"2016","journal-title":"Methods Mol Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"10277","DOI":"10.1073\/pnas.89.21.10277","article-title":"Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin","volume":"89","author":"Klimpel","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1042\/BJ20050426","article-title":"Resolving the energy paradox of chaperone\/usher-mediated fibre assembly","volume":"389","author":"Zavialov","year":"2005","journal-title":"Biochem J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1128\/IAI.74.1.794-797.2006","article-title":"Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen","volume":"74","author":"Peachman","year":"2006","journal-title":"Infect Immun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"6802","DOI":"10.1016\/j.vaccine.2010.12.062","article-title":"Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1128\/IAI.00269-13","article-title":"Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed","volume":"81","author":"Ovsyannikova","year":"2013","journal-title":"Infect Immun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e112802","DOI":"10.1371\/journal.pone.0112802","article-title":"Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles","volume":"9","author":"Rosenthal","year":"2014","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1016\/j.vaccine.2012.04.078","article-title":"Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague","volume":"30","author":"Albrecht","year":"2012","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"7436","DOI":"10.1016\/j.vaccine.2009.07.015","article-title":"Protection against anthrax and plague by a combined vaccine in mice and rabbits","volume":"27","author":"Ren","year":"2009","journal-title":"Vaccine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.femsim.2004.10.012","article-title":"Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine","volume":"43","author":"Griffin","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1016\/S0264-410X(02)00232-3","article-title":"Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague","volume":"20","author":"Williamson","year":"2002","journal-title":"Vaccine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.micinf.2008.11.009","article-title":"Characterization of the rat pneumonic plague model: infection kinetics following aerosolization of Yersinia pestis CO92","volume":"11","author":"Agar","year":"2009","journal-title":"Microbes Infect"},{"key":"B44","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1128\/IAI.00719-06","article-title":"Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax","volume":"74","author":"Heninger","year":"2006","journal-title":"Infect Immun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"17786","DOI":"10.1073\/pnas.0506840102","article-title":"Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity","volume":"102","author":"Lathem","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.micpath.2012.09.011","article-title":"A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague","volume":"55","author":"Sha","year":"2013","journal-title":"Microb Pathog"},{"key":"B47","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1177\/0300985810378112","article-title":"Pathology of inhalational anthrax animal models","volume":"47","author":"Twenhafel","year":"2010","journal-title":"Vet Pathol"},{"key":"B48","first-page":"982","article-title":"The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation","volume":"122","author":"Zaucha","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1128\/IAI.06340-11","article-title":"Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax","volume":"80","author":"Lovchik","year":"2012","journal-title":"Infect Immun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/CVI.00690-14","article-title":"Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model","volume":"22","author":"Krishnan","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1073\/pnas.1300867110","article-title":"In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine","volume":"110","author":"Tao","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B53","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1128\/IAI.62.11.4955-4961.1994","article-title":"Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells","volume":"62","author":"Arora","year":"1994","journal-title":"Infect Immun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/sj.jim.7000239","article-title":"Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis","volume":"28","author":"Ramirez","year":"2002","journal-title":"J Ind Microbiol Biotechnol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"36741","DOI":"10.1074\/jbc.M003848200","article-title":"Polyarginines are potent furin inhibitors","volume":"275","author":"Cameron","year":"2000","journal-title":"J Biol Chem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nature02763","article-title":"Crystal structure of a complex between anthrax toxin and its host cell receptor","volume":"430","author":"Santelli","year":"2004","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"13487","DOI":"10.1073\/pnas.0906581106","article-title":"Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding","volume":"106","author":"Chen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00687\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T21:43:13Z","timestamp":1602366193000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00687\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,26]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2017.00687"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00687","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,26]]},"article-number":"687"}}